Research by Delvecchio et al. (2021) indicated that intra-tumoral injection of CXCL13 and CCL21 recruited CCR5+ B cells and T cells into tumors, promoted TLS formation, and prolonged survival in pancreatic ductal adenocarcinoma mouse models. The gene discussed is CXCL13; the disease is pancreatic ductal adenocarcinoma.